Article
forge aao symposia
Retinoblastoma care goes digital: insights from two decades of teleophthalmology
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Clearside Biomedical presents new data from CLS-AX ODYSSEY phase 2b trial
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb provides update on potential sale
4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study